ome

Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients

Janssen sponsored industry session at ESMO 2022
Agenda

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate updates in the molecular diagnosis of EGFR-mutant NSCLC
  • Reflect on how recent advances in the management of EGFR-mutant NSCLC may impact clinical practice

 

Faculty:

  • David Planchard (France)
  • Rosario García Campelo (Spain)
  • Sanjay Popat (UK)
  • Paul Hofman (France)
  • Anne-Marie Dingemans (Netherlands)

 

Claim your CPD credits

The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1.5 credits for this activity.
Please make a note of the below information to claim your points.

Name of activity: Precision approaches in EGFR-Mutant NSCLC: Optimising outcomes for patients, 10 September 2022, Paris

Certificate number: A038287
Date of activity: October 2022
CPD Provider: Sciterion 013096

 

 

More Info
88 Minutes
EM-106732 - Date of preparation: October 2022